Champions Oncology Inc (CSBR) is a Healthcare · Biotechnology company listed on NASDAQ. Price $5.30 (+4.33%), Market cap $0.08B, 52-week low–high $5.72 ~ $8.91.
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical s
Financial statements, price targets, institutional (13F) holdings and related news for Champions Oncology Inc are updated in real time on BlackAll Trade.
Champions Oncology Inc trades at $5.30 (+4.33%). Real-time quotes and charts are available on BlackAll Trade.
Champions Oncology Inc has a market cap of about $0.08B.
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology p